Caribou Biosciences, Inc.CRBUNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank17
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-148.34M
↓ 54% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-96.40M
Historical baseline
PeriodValueYoY Change
TTM$-148.34M+11.0%
2024$-166.62M-43.6%
2023$-116.06M-9.1%
2022$-106.40M-58.9%
2021$-66.98M-85.4%
2020$-36.12M-5.3%
2019$-34.30M-